{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:58:44Z","timestamp":1794441524975,"version":"4.9.1"},"reference-count":361,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2314,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1002\/hep.22772","type":"journal-article","created":{"date-parts":[[2008,12,9]],"date-time":"2008-12-09T22:29:45Z","timestamp":1228861785000},"page":"1729-1764","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":829,"title":["Vascular disorders of the liver # \u2020"],"prefix":"10.1097","volume":"49","author":[{"given":"Laurie D.","family":"DeLeve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique-Charles","family":"Valla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Garcia-Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-36-20241201","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0016-5085(95)90469-7","article-title":"Position and policy statement: American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers.","volume":"108","year":"1995","journal-title":"Gastroenterology"},{"key":"R3-36-20241201","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-139-6-200309160-00013","article-title":"Standardized reporting of clinical practice guidelines: a proposal from the conference on guideline standardization.","volume":"139","author":"Shiffman","year":"2003","journal-title":"Ann Intern Med"},{"key":"R5-36-20241201","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","article-title":"Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies.","volume":"12","author":"Ogren","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R6-36-20241201","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF02730901","article-title":"Portal hypertension in north Indian children.","volume":"65","author":"Arora","year":"1998","journal-title":"Indian J Pediatr"},{"key":"R7-36-20241201","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/jhep.2000.16597","article-title":"Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy.","volume":"32","author":"Condat","year":"2000","journal-title":"HEPATOLOGY"},{"key":"R8-36-20241201","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0016-5085(99)70238-6","article-title":"Frequent factor II G20210A mutation in idiopathic portal vein thrombosis.","volume":"116","author":"Chamouard","year":"1999","journal-title":"Gastroenterology"},{"key":"R9-36-20241201","first-page":"2364","article-title":"Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with BuddChiari syndrome and portal vein thrombosis: results of a casecontrol study.","volume":"96","author":"Janssen","year":"2000","journal-title":"Blood"},{"key":"R10-36-20241201","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.20591","article-title":"Risk factors for thrombophilia in extrahepatic portal vein obstruction.","volume":"41","author":"Primignani","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R11-36-20241201","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.510310307","article-title":"Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.","volume":"31","author":"Denninger","year":"2000","journal-title":"HEPATOLOGY"},{"key":"R12-36-20241201","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/clinids\/21.5.1114","article-title":"Septic thrombophlebitis of the portal vein (pylephlebitis): diagnosis and management in the modern era.","volume":"21","author":"Plemmons","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R13-36-20241201","first-page":"627","article-title":"The aetiology, presentation and natural history of extrahepatic portal venous obstruction.","volume":"48","author":"Webb","year":"1979","journal-title":"Q J Med"},{"key":"R14-36-20241201","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1309\/F2U1XBV4RXYUAYG0","article-title":"Inherited prothrombotic defects in BuddChiari syndrome and portal vein thrombosis: a study from North India.","volume":"121","author":"Bhattacharyya","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R15-36-20241201","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/gut.40.6.798","article-title":"Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis.","volume":"40","author":"Mahmoud","year":"1997","journal-title":"Gut"},{"key":"R16-36-20241201","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/jhep.2001.27948","article-title":"Hereditary thrombophilia as a cause of BuddChiari syndrome: a study from Western India.","volume":"34","author":"Mohanty","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R17-36-20241201","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1046\/j.1440-1746.1999.02030.x","article-title":"Coagulation abnormalities in idiopathic portal venous thrombosis.","volume":"14","author":"Ahuja","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"R18-36-20241201","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1572-0241.2001.03465.x","article-title":"High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis.","volume":"96","author":"Amitrano","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R19-36-20241201","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00004836-200001000-00013","article-title":"The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis.","volume":"30","author":"Egesel","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"R20-36-20241201","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/pgmj.2006.046987","article-title":"Venous thromboembolic disease and cancer.","volume":"82","author":"Fennerty","year":"2006","journal-title":"Postgrad Med J"},{"key":"R21-36-20241201","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ccc.2005.04.004","article-title":"Sepsis and coagulation.","volume":"21","author":"Aird","year":"2005","journal-title":"Crit Care Clin"},{"key":"R22-36-20241201","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2141.2005.05490.x","article-title":"Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis.","volume":"129","author":"Chait","year":"2005","journal-title":"Br J Haematol"},{"key":"R23-36-20241201","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0016-5085(88)90567-7","article-title":"Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders.","volume":"94","author":"Valla","year":"1988","journal-title":"Gastroenterology"},{"key":"R24-36-20241201","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1538-7836.2006.02277.x","article-title":"The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis.","volume":"5","author":"Colaizzo","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R25-36-20241201","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1538-7836.2007.02424.x","article-title":"Prevalence of the JAK2(V617F) mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders.","volume":"5","author":"De Stefano","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R26-36-20241201","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1182\/blood-2007-11-125328","article-title":"The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases.","volume":"111","author":"Kiladjian","year":"2008","journal-title":"Blood"},{"key":"R27-36-20241201","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/hep.21435","article-title":"Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis.","volume":"44","author":"Primignani","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R28-36-20241201","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gut.46.4.534","article-title":"Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?","volume":"46","author":"Fisher","year":"2000","journal-title":"Gut"},{"key":"R29-36-20241201","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","article-title":"Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.","volume":"40","author":"Amitrano","year":"2004","journal-title":"J Hepatol"},{"key":"R30-36-20241201","first-page":"581","article-title":"Portal thrombosis and liver cirrhosis. Value of ultrasoundguided puncturebiopsy of the thrombus.","volume":"19","author":"Duchmann","year":"1995","journal-title":"in French Gastroenterol Clin Biol"},{"key":"R31-36-20241201","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00261-005-0150-x","article-title":"Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrastenhanced US, and fineneedle biopsy.","volume":"31","author":"Tarantino","year":"2006","journal-title":"Abdom Imaging"},{"key":"R32-36-20241201","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00042737-199308000-00018","article-title":"Bacteroides bacteremia of undetermined origin: strong association with portal vein thrombosis and cryptogenic pylephlebitis.","volume":"5","author":"Trum","year":"1993","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R33-36-20241201","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0016-5085(82)90028-2","article-title":"Mesenteric venous thrombosis.","volume":"82","author":"Grendell","year":"1982","journal-title":"Gastroenterology"},{"key":"R34-36-20241201","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/qjmed\/93.8.531","article-title":"Clinical features, diagnosis and outcome of acute portal vein thrombosis.","volume":"93","author":"Sheen","year":"2000","journal-title":"Q J Med"},{"key":"R35-36-20241201","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/bjs.1800770602","article-title":"Diagnosis and management of mesenteric infarction.","volume":"77","author":"Clavien","year":"1990","journal-title":"Br J Surg"},{"key":"R36-36-20241201","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0168-8278(00)80259-7","article-title":"Portal vein thrombosis in adults: pathophysiology, pathogenesis and management.","volume":"32","author":"Valla","year":"2000","journal-title":"J Hepatol"},{"key":"R37-36-20241201","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJMra010076","article-title":"Mesenteric venous thrombosis.","volume":"345","author":"Kumar","year":"2001","journal-title":"N Engl J Med"},{"key":"R38-36-20241201","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0140-6736(06)69116-2","article-title":"Pylephlebitis complicating silent diverticulitis.","volume":"368","author":"Dourakis","year":"2006","journal-title":"Lancet"},{"key":"R39-36-20241201","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF01888505","article-title":"MR, CT, and ultrasonography of splanchnic venous thrombosis.","volume":"17","author":"Haddad","year":"1992","journal-title":"Gastrointest Radiol"},{"key":"R40-36-20241201","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1148\/radiology.216.1.r00jl2386","article-title":"Detection of thrombosis in the portal venous system: comparison of contrastenhanced MR angiography with intraarterial digital subtraction angiography.","volume":"216","author":"Kreft","year":"2000","journal-title":"Radiology"},{"key":"R41-36-20241201","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01888529","article-title":"Value of CT and sonography in the conservative management of acute splenoportal and superior mesenteric venous thrombosis.","volume":"17","author":"Rahmouni","year":"1992","journal-title":"Gastrointest Radiol"},{"key":"R42-36-20241201","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2214\/ajr.157.2.1853809","article-title":"Diagnosis of portal vein thrombosis: value of color Doppler imaging.","volume":"157","author":"Tessler","year":"1991","journal-title":"AJR Am J Roentgenol"},{"key":"R43-36-20241201","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0016-5107(95)70237-7","article-title":"Duplex Doppler endosonography in the diagnosis of splenic vein, portal vein, and portosystemic shunt thrombosis.","volume":"42","author":"Wiersema","year":"1995","journal-title":"Gastrointest Endosc"},{"key":"R44-36-20241201","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2214\/ajr.144.4.749","article-title":"Sonographic features of portal vein thrombosis.","volume":"144","author":"Van Gansbeke","year":"1985","journal-title":"AJR Am J Roentgenol"},{"key":"R45-36-20241201","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiology.201.1.8816536","article-title":"Portal vein evaluation with US: comparison to angiography combined with CT arterial portography.","volume":"201","author":"Bach","year":"1996","journal-title":"Radiology"},{"key":"R46-36-20241201","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1148\/radiology.154.3.3881793","article-title":"Portal thrombosis: dynamic CT features and course.","volume":"154","author":"Mathieu","year":"1985","journal-title":"Radiology"},{"key":"R47-36-20241201","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00261-003-0073-3","article-title":"CT of small bowel ischemia.","volume":"29","author":"Chou","year":"2004","journal-title":"Abdom Imaging"},{"key":"R48-36-20241201","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF00316845","article-title":"Doppler demonstration of cystic vein dilatation secondary to portal vein thrombosis.","volume":"5","author":"Cerri","year":"1991","journal-title":"Surg Endosc"},{"key":"R50-36-20241201","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1056\/NEJMcp031676","article-title":"Clinical practice. Treatment of deepvein thrombosis.","volume":"351","author":"Bates","year":"2004","journal-title":"N Engl J Med"},{"key":"R51-36-20241201","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2168.2000.01383-16.x","article-title":"Portal vein thrombosis following splenectomy.","volume":"87","author":"Hassn","year":"2000","journal-title":"Br J Surg"},{"key":"R52-36-20241201","first-page":"919","article-title":"Acute thrombosis of the portal system. Treatment with alteplase and heparin or with heparin alone in 10 patients.","volume":"21","author":"Lagasse","year":"1997","journal-title":"in French Gastroenterol Clin Biol"},{"key":"R53-36-20241201","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.05.009","article-title":"Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.","volume":"43","author":"de Franchis","year":"2005","journal-title":"J Hepatol"},{"key":"R54-36-20241201","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-137-12-200212170-00008","article-title":"Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism.","volume":"137","author":"Prandoni","year":"2002","journal-title":"Ann Intern Med"},{"key":"R55-36-20241201","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.RVI.0000156265.79960.86","article-title":"Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis.","volume":"16","author":"Hollingshead","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"R56-36-20241201","first-page":"2098","article-title":"Thrombolytic treatment of portal thrombosis.","volume":"50","author":"Malkowski","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"R57-36-20241201","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/153857440503900603","article-title":"Deciphering mesenteric venous thrombosis: imaging and treatment.","volume":"39","author":"Grisham","year":"2005","journal-title":"Vasc Endovascular Surg"},{"key":"R58-36-20241201","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1067\/mva.2001.117331","article-title":"Acute mesenteric venous thrombosis: case for nonoperative management.","volume":"34","author":"Brunaud","year":"2001","journal-title":"J Vasc Surg"},{"key":"R59-36-20241201","first-page":"383","article-title":"Mesenteric venous thrombosis-1911 to 1984.","volume":"101","author":"Abdu","year":"1987","journal-title":"Surgery"},{"key":"R60-36-20241201","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejvs.2004.10.005","article-title":"Mesenteric and portal vein thrombosis: treated with early initiation of anticoagulation.","volume":"29","author":"Joh","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R61-36-20241201","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/gut.37.2.292","article-title":"Small intestinal stricture complicating superior mesenteric vein thrombosis. A study of three cases.","volume":"37","author":"Eugene","year":"1995","journal-title":"Gut"},{"key":"R62-36-20241201","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1053\/jhep.2003.50232","article-title":"Portal cavernomaassociated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study.","volume":"37","author":"Condat","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R63-36-20241201","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.1840170510","article-title":"Biliary abnormalities associated with extrahepatic portal venous obstruction.","volume":"17","author":"Khuroo","year":"1993","journal-title":"HEPATOLOGY"},{"key":"R64-36-20241201","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/gast.2001.21209","article-title":"Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy.","volume":"120","author":"Condat","year":"2001","journal-title":"Gastroenterology"},{"key":"R65-36-20241201","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.21126","article-title":"Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.","volume":"43","author":"Minguez","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R66-36-20241201","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1111\/j.1572-0241.2001.05274.x","article-title":"Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction.","volume":"96","author":"Gupta","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R67-36-20241201","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/(SICI)1097-0096(199706)25:5<227::AID-JCU2>3.0.CO;2-F","article-title":"Color Doppler ultrasonography in the diagnosis of cavernous transformation of the portal vein.","volume":"25","author":"Ueno","year":"1997","journal-title":"J Clin Ultrasound"},{"key":"R68-36-20241201","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1055\/s-2003-38779","article-title":"Diagnosis and treatment of biliary obstruction caused by portal cavernoma.","volume":"35","author":"Dumortier","year":"2003","journal-title":"Endoscopy"},{"key":"R69-36-20241201","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-2000-9009","article-title":"Biliary varices on endoscopic ultrasonography: clinical presentation and outcome.","volume":"32","author":"Palazzo","year":"2000","journal-title":"Endoscopy"},{"key":"R70-36-20241201","first-page":"322","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.","volume":"46","author":"GarciaTsao","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R71-36-20241201","first-page":"212A","article-title":"Chronic portomesenteric and portosplenomesenteric venous thrombosis: evaluation of long term followup and determinants of survival. Abstract.","volume":"42","author":"Orr","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R72-36-20241201","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00000658-199401000-00006","article-title":"A 15year experience of injection sclerotherapy in adult patients with extrahepatic portal venous obstruction.","volume":"219","author":"Kahn","year":"1994","journal-title":"Ann Surg"},{"key":"R73-36-20241201","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00042737-199801000-00015","article-title":"Endoscopic sclerotherapy for bleeding oesophagogastric varices secondary to extrahepatic portal vein obstruction in an adult Caucasian population.","volume":"10","author":"Vleggaar","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R75-36-20241201","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00000658-198805000-00017","article-title":"Management of variceal bleeding in patients with noncirrhotic portal vein thrombosis.","volume":"207","author":"Warren","year":"1988","journal-title":"Ann Surg"},{"key":"R76-36-20241201","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2036.2006.02820.x","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation.","volume":"23","author":"Senzolo","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R77-36-20241201","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11239-006-9017-4","article-title":"Chronic oral anticoagulant therapy for extrahepatic visceral thrombosis is safe.","volume":"23","author":"Kitchens","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"R78-36-20241201","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1365-2168.1998.00591.x","article-title":"Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: surgical management.","volume":"85","author":"Chaudhary","year":"1998","journal-title":"Br J Surg"},{"key":"R79-36-20241201","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1478-3231.2006.01269.x","article-title":"Consensus on extrahepatic portal vein obstruction.","volume":"26","author":"Sarin","year":"2006","journal-title":"Liver Int"},{"key":"R80-36-20241201","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jpedsurg.2005.12.027","article-title":"Extrahepatic portal vein morphology in children with extrahepatic portal hypertension assessed by 3dimensional computed tomographic portography: a new etiology of extrahepatic portal hypertension.","volume":"41","author":"Shinohara","year":"2006","journal-title":"J Pediatr Surg"},{"key":"R81-36-20241201","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.10192","article-title":"PAI1 gene 4G5G genotype: A risk factor for thrombosis in vessels of internal organs.","volume":"71","author":"Balta","year":"2002","journal-title":"Am J Hematol"},{"key":"R82-36-20241201","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0168-8278(97)80292-9","article-title":"Protein C, protein S and antithrombin III in children with portal vein obstruction.","volume":"27","author":"Dubuisson","year":"1997","journal-title":"J Hepatol"},{"key":"R83-36-20241201","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00277-004-0921-4","article-title":"Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a singlecenter casecontrol study.","volume":"83","author":"ElKaraksy","year":"2004","journal-title":"Ann Hematol"},{"key":"R84-36-20241201","first-page":"534","article-title":"Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors a multicentre casecontrol study. For the Childhood Thrombophilia Study Group.","volume":"111","author":"Heller","year":"2000","journal-title":"Br J Haematol"},{"key":"R85-36-20241201","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2223\/JPED.969","article-title":"Thrombophilic disorders in children and adolescents with portal vein thrombosis.","volume":"79","author":"Pinto","year":"2003","journal-title":"in Portugese J Pediatr (Rio J)"},{"key":"R86-36-20241201","first-page":"47","article-title":"Functional protein C and anticardiolipin antibody in children with portal vein thrombosis.","volume":"20","author":"Yachha","year":"2001","journal-title":"Indian J Gastroenterol"},{"key":"R87-36-20241201","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1067\/mpd.2003.93","article-title":"Surgical restoration of portal flow corrects procoagulant and anticoagulant deficiencies associated with extrahepatic portal vein thrombosis.","volume":"142","author":"Mack","year":"2003","journal-title":"J Pediatr"},{"key":"R88-36-20241201","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jpeds.2006.01.051","article-title":"Portal vein thrombosis in the neonate: risk factors, course, and outcome.","volume":"148","author":"Morag","year":"2006","journal-title":"J Pediatr"},{"key":"R89-36-20241201","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1590\/S0004-28032003000400009","article-title":"Growth assessment in children with extrahepatic portal vein obstruction and portal hypertension.","volume":"40","author":"BellomoBrandao","year":"2003","journal-title":"Arq Gastroenterol"},{"key":"R90-36-20241201","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/jhep.2002.35278","article-title":"Endoscopic ligation compared with sclerotherapy for bleeding esophageal varices in children with extrahepatic portal venous obstruction.","volume":"36","author":"Zargar","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R91-36-20241201","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/bmj.295.6606.1115","article-title":"Operations for portal hypertension due to extrahepatic obstruction: results and 10 year follow up.","volume":"295","author":"Pande","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R92-36-20241201","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/01.sla.0000205827.73706.97","article-title":"Correction of extrahepatic portal vein thrombosis by the mesenteric to left portal vein bypass.","volume":"243","author":"Superina","year":"2006","journal-title":"Ann Surg"},{"key":"R93-36-20241201","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0016-5085(85)90327-0","article-title":"Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients.","volume":"89","author":"Okuda","year":"1985","journal-title":"Gastroenterology"},{"key":"R94-36-20241201","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gut.2004.042796","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.","volume":"54","author":"Francoz","year":"2005","journal-title":"Gut"},{"key":"R95-36-20241201","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2214\/ajr.168.3.9057522","article-title":"3rd, Baron RL. Benign and malignant portal vein thrombosis: differentiation by CT characteristics.","volume":"168","author":"Tublin","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"R96-36-20241201","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2214\/AJR.04.1218","article-title":"Contrastenhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems.","volume":"186","author":"Rossi","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"R97-36-20241201","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/hep.1840160515","article-title":"The incidence of portal vein thrombosis at liver transplantation.","volume":"16","author":"Nonami","year":"1992","journal-title":"HEPATOLOGY"},{"key":"R98-36-20241201","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hep.510310213","article-title":"Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis.","volume":"31","author":"Amitrano","year":"2000","journal-title":"HEPATOLOGY"},{"key":"R99-36-20241201","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-2002-33210","article-title":"Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia.","volume":"34","author":"Amitrano","year":"2002","journal-title":"Endoscopy"},{"key":"R100-36-20241201","first-page":"179","article-title":"Treatment of vascular complications following liver transplantation: multidisciplinary approach.","volume":"48","author":"Cavallari","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"R101-36-20241201","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1034\/j.1399-0012.2000.140309.x","article-title":"Venous complications after orthotopic liver transplantation.","volume":"14","author":"Settmacher","year":"2000","journal-title":"Clin Transplant"},{"key":"R102-36-20241201","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.1840190515","article-title":"Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.","volume":"19","author":"Shulman","year":"1994","journal-title":"HEPATOLOGY"},{"key":"R103-36-20241201","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.510230326","article-title":"Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venooclusive disease.","volume":"23","author":"DeLeve","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R104-36-20241201","doi-asserted-by":"crossref","first-page":"G1045","DOI":"10.1152\/ajpgi.00526.2002","article-title":"Embolization by sinusoidal lining cell obstructs the microcirculation in rat sinusoidal obstruction syndrome.","volume":"284","author":"DeLeve","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R105-36-20241201","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Venoocclusive disease of the liver and multiorgan failure after bone marrow transplantation a cohort study of 355 patients.","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"R106-36-20241201","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1083-8791(99)70006-6","article-title":"Venoocclusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.","volume":"5","author":"Lee","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"R107-36-20241201","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.bbmt.2007.08.002","article-title":"Venoocclusive disease of the liver after highdose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.","volume":"13","author":"Carreras","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R108-36-20241201","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.bmt.1704464","article-title":"Liver disease of uncertain cause.","volume":"33","author":"McDonald","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R109-36-20241201","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation.","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"R110-36-20241201","first-page":"439","article-title":"A comparison of clinical criteria for the diagnosis of venoocclusive disease of the liver after bone marrow transplantation.","volume":"10","author":"Blostein","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"R111-36-20241201","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1148\/radiology.184.3.1509050","article-title":"Venocclusive disease of the liver: prospective study of US evaluation.","volume":"184","author":"Hommeyer","year":"1992","journal-title":"Radiology"},{"key":"R112-36-20241201","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2214\/ajr.164.6.7754881","article-title":"Diagnosis of venoocclusive disease of the liver after bone marrow transplantation: value of duplex sonography.","volume":"164","author":"Teefey","year":"1995","journal-title":"Am J Roentgenol"},{"key":"R113-36-20241201","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s002470000373","article-title":"Hepatic venoocclusive disease in children undergoing bonemarrow transplantation: usefulness of sonographic findings.","volume":"31","author":"McCarville","year":"2001","journal-title":"Pediatr Radiol"},{"key":"R114-36-20241201","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1148\/radiology.204.2.9240551","article-title":"Hepatic venoocclusive disease after myeloablative treatment and bone marrow transplantation: value of grayscale and Doppler US in 100 patients.","volume":"204","author":"Lassau","year":"1997","journal-title":"Radiology"},{"key":"R115-36-20241201","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00007890-200207150-00011","article-title":"Prognostic value of dopplerultrasonography in hepatic venoocclusive disease.","volume":"74","author":"Lassau","year":"2002","journal-title":"Transplantation"},{"key":"R116-36-20241201","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/00007890-199504150-00017","article-title":"Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients.","volume":"59","author":"Shulman","year":"1995","journal-title":"Transplantation"},{"key":"R117-36-20241201","first-page":"21","article-title":"Transjugular liver biopsy in BMT.","volume":"11","author":"Carreras","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"R118-36-20241201","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","article-title":"Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.","volume":"11","author":"Bearman","year":"1993","journal-title":"J Clin Oncol"},{"key":"R119-36-20241201","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00007890-198506000-00005","article-title":"The clinical course of 53 patients with venocclusive disease of the liver after marrow transplantation.","volume":"36","author":"McDonald","year":"1985","journal-title":"Transplantation"},{"key":"R120-36-20241201","first-page":"3599","article-title":"Incidence and outcome of hepatic venoocclusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"R121-36-20241201","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0360-3016(88)90009-0","article-title":"Venocclusive disease of the liver after allogeneic bone marrow transplantation in man.","volume":"14","author":"Ganem","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R122-36-20241201","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bmt.1701506","article-title":"Venoocclusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.","volume":"22","author":"Hasegawa","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R123-36-20241201","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0002-9610(84)90006-0","article-title":"BuddChiari syndrome. Historical and clinical review with an analysis of surgical corrective procedures.","volume":"147","author":"McDermott","year":"1984","journal-title":"Am J Surg"},{"key":"R124-36-20241201","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood-2003-01-0255","article-title":"Prior gemtuzumab ozogamicin exposure significantly increases the risk of venoocclusive disease in patients who undergo myeloablative allogeneic stem cell transplantation.","volume":"102","author":"Wadleigh","year":"2003","journal-title":"Blood"},{"key":"R125-36-20241201","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/00007890-198706000-00020","article-title":"Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation.","volume":"43","author":"Dulley","year":"1987","journal-title":"Transplantation"},{"key":"R126-36-20241201","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00043426-200212000-00013","article-title":"Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients.","volume":"24","author":"Reiss","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"R127-36-20241201","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/blood.V83.7.1998.1998","article-title":"Hepatitis C virus infection is a risk factor for liver failure from venoocclusive disease after bone marrow transplantation.","volume":"83","author":"Frickhofen","year":"1994","journal-title":"Blood"},{"key":"R128-36-20241201","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.510290609","article-title":"Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10year followup.","volume":"29","author":"Strasser","year":"1999","journal-title":"HEPATOLOGY"},{"key":"R129-36-20241201","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bmt.1705109","article-title":"Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia.","volume":"36","author":"Cordonnier","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R130-36-20241201","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2003-04-1311","article-title":"Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.","volume":"103","author":"Hogan","year":"2004","journal-title":"Blood"},{"key":"R131-36-20241201","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V76.9.1867.1867","article-title":"Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.","volume":"76","author":"Clift","year":"1990","journal-title":"Blood"},{"key":"R132-36-20241201","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/hep.510240414","article-title":"Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation.","volume":"24","author":"DeLeve","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R133-36-20241201","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","article-title":"Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation.","volume":"101","author":"McDonald","year":"2003","journal-title":"Blood"},{"key":"R134-36-20241201","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clpt.2005.05.005","article-title":"Metabolismbased cyclophosphamide dosing for hematopoietic cell transplant.","volume":"78","author":"McDonald","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R135-36-20241201","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1158\/1078-0432.CCR-05-2079","article-title":"Realtime dose adjustment of cyclophosphamide in a preparative regimen for hematopoietic cell transplant: a Bayesian pharmacokinetic approach.","volume":"12","author":"Salinger","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R136-36-20241201","first-page":"18","article-title":"Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens.","volume":"20","author":"Grochow","year":"1993","journal-title":"Semin Oncol"},{"key":"R137-36-20241201","first-page":"491","article-title":"Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.","volume":"17","author":"Demirer","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R138-36-20241201","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/bbmt.2002.v8.abbmt080619","article-title":"A limited sample strategy for pharmacokinetic therapy with intravenous busulfan.","volume":"8","author":"Vaughan","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"R139-36-20241201","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/10428199609054777","article-title":"Aspects concerning busulfan pharmacokinetics and bioavailability.","volume":"22","author":"Hassan","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"R140-36-20241201","first-page":"135","article-title":"Risk factors for hepatic venoocclusive disease after highdose busulfancontaining regimens followed by autologous bone marrow transplantation: a study in 136 children.","volume":"10","author":"Meresse","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"R141-36-20241201","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0301-472X(03)00047-X","article-title":"Intravenous busulfanbased conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity.","volume":"31","author":"Shimoni","year":"2003","journal-title":"Exp Hematol"},{"key":"R142-36-20241201","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00277-004-0982-4","article-title":"Decreased incidence of hepatic venoocclusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan cyclophosphamide for allogeneic bone marrow transplantation.","volume":"84","author":"Lee","year":"2005","journal-title":"Ann Hematol"},{"key":"R143-36-20241201","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/bbmt.2002.v8.pm12374454","article-title":"Intravenous versus oral busulfan as part of a busulfancyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVODrelated mortality, and overall 100day mortality.","volume":"8","author":"Kashyap","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"R144-36-20241201","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00694339","article-title":"Pharmacokinetics of busulfan: correlation with venoocclusive disease in patients undergoing bone marrow transplantation.","volume":"25","author":"Grochow","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"R145-36-20241201","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.bmt.1703207","article-title":"Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens.","volume":"28","author":"Bleyzac","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R146-36-20241201","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bmt.1701322","article-title":"Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation.","volume":"22","author":"Schuler","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R147-36-20241201","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1182\/blood.V89.8.3055","article-title":"Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.","volume":"89","author":"Slattery","year":"1997","journal-title":"Blood"},{"key":"R148-36-20241201","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.bmt.1704707","article-title":"Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity.","volume":"35","author":"Zwaveling","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R149-36-20241201","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2002-11-3567","article-title":"Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells.","volume":"102","author":"Bornhauser","year":"2003","journal-title":"Blood"},{"key":"R150-36-20241201","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2141.1996.4771012.x","article-title":"Treatment of newlydiagnosed acute myelogenous leukaemia in patients aged 80 years and above.","volume":"93","author":"DeLima","year":"1996","journal-title":"Br J Haematol"},{"key":"R151-36-20241201","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1182\/blood.V92.12.4568","article-title":"Norethisterone treatment, a major riskfactor for venoocclusive disease in the liver after allogeneic bone marrow transplantation.","volume":"92","author":"Hagglund","year":"1998","journal-title":"Blood"},{"key":"R152-36-20241201","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.V82.3.732.732","article-title":"Prevention of regimenrelated toxicities after bone marrow transplantation by pentoxifylline a prospective, randomized trial.","volume":"82","author":"Attal","year":"1993","journal-title":"Blood"},{"key":"R153-36-20241201","first-page":"185","article-title":"Phase II trial of heparin prophylaxis for venoocclusive disease of the liver in children undergoing bone marrow transplantation.","volume":"18","author":"Rosenthal","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R154-36-20241201","first-page":"407","article-title":"A pilot study of continuous infusion heparin for the prevention of hepatic venoocclusive disease after bone marrow transplantation.","volume":"5","author":"Bearman","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"R155-36-20241201","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0609.1991.tb01859.x","article-title":"Prophylactic heparin does not prevent liver venoocclusive disease following autologous bone marrow transplantation.","volume":"47","author":"MarsaVila","year":"1991","journal-title":"Eur J Haematol"},{"key":"R156-36-20241201","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1705297","article-title":"Use of prophylactic anticoagulation and the risk of hepatic venoocclusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and metaanalysis.","volume":"37","author":"Imran","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R157-36-20241201","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, doubleblind, placebocontrolled trial.","volume":"128","author":"Essell","year":"1998","journal-title":"Ann Intern Med"},{"key":"R158-36-20241201","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic venoocclusive disease after stem cell transplantation.","volume":"64","author":"Ohashi","year":"2000","journal-title":"Am J Hematol"},{"key":"R159-36-20241201","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"R160-36-20241201","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bmt.1703342","article-title":"A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic venoocclusive disease after hematopoietic stem cell transplantation.","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R161-36-20241201","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic venoocclusive disease in hematopoietic stem cell transplantation.","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R162-36-20241201","first-page":"1","article-title":"Role of PGE1 to prevent venoocclusive disease of the liver after bone marrow transplantation.","volume":"32","author":"Gluckman","year":"1990","journal-title":"Nouv Rev Fr Hematol"},{"key":"R163-36-20241201","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2141.1993.tb03152.x","article-title":"A phaseI phaseII study of prostaglandin E1 for the prevention of hepatic venoocclusive disease after bone marrow transplantation.","volume":"84","author":"Bearman","year":"1993","journal-title":"Br J Haematol"},{"key":"R164-36-20241201","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V82.7.2025.2025","article-title":"A randomized controlled trial of pentoxifylline for the prevention of regimenrelated toxicities in patients undergoing allogeneic marrow transplantation.","volume":"82","author":"Clift","year":"1993","journal-title":"Blood"},{"key":"R165-36-20241201","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/sj.bmt.1705969","article-title":"A prospective randomized study using NacetylLcysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation.","volume":"41","author":"Barkholt","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R166-36-20241201","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V89.5.1501","article-title":"Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients.","volume":"89","author":"Bearman","year":"1997","journal-title":"Blood"},{"key":"R167-36-20241201","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.bmt.1701654","article-title":"Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic venoocclusive disease (VOD).","volume":"23","author":"Kulkarni","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R168-36-20241201","first-page":"3535","article-title":"No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic venoocclusive disease after allogeneic bone marrow transplantation.","volume":"27","author":"Hagglund","year":"1995","journal-title":"Transplant Proc"},{"key":"R169-36-20241201","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-199610270-00009","article-title":"Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation.","volume":"62","author":"Hagglund","year":"1996","journal-title":"Transplantation"},{"key":"R170-36-20241201","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00005344-199101000-00016","article-title":"Stimulation of prostacyclin synthesis by defibrotide: improved contractile recovery from myocardial stunning.","volume":"17","author":"Hohlfeld","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"R171-36-20241201","first-page":"511","article-title":"Modulation of arachidonate metabolite generation in human blood by oral defibrotide.","volume":"41","author":"Biagi","year":"1991","journal-title":"Arzneimittelforschung"},{"key":"R172-36-20241201","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0049-3848(00)00256-5","article-title":"Protective effect of defibrotide on perfusion induced endothelial damage.","volume":"99","author":"San","year":"2000","journal-title":"Thromb Res"},{"key":"R173-36-20241201","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1476-5381.1995.tb14978.x","article-title":"Polydeoxyribonucleotides and nitric oxide release from guineapig hearts during ischaemia and reperfusion.","volume":"115","author":"Masini","year":"1995","journal-title":"Br J Pharmacol"},{"key":"R174-36-20241201","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005344-199308000-00023","article-title":"Nitric oxide and prostacyclin influence coronary vasomotor tone in perfused rabbit heart and modulate endothelin1 activity.","volume":"22","author":"Berti","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"R175-36-20241201","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1476-5381.1996.tb15427.x","article-title":"Druginduced in vitro inhibition of neutrophilendothelial cell adhesion.","volume":"118","author":"Pellegatta","year":"1996","journal-title":"Br J Pharmacol"},{"key":"R176-36-20241201","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0049-3848(92)90054-E","article-title":"Acute tPA release by defibrotide.","volume":"66","author":"Klocking","year":"1992","journal-title":"Thromb Res"},{"key":"R177-36-20241201","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(93)90864-E","article-title":"Defibrotide, a singlestranded polydeoxyribonucleotide acting as an adenosine receptor agonist.","volume":"238","author":"Bianchi","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"R178-36-20241201","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-2007-1000400","article-title":"Defibrotide reduces monocyte PAI2 and procoagulant activity.","volume":"21","author":"Abbate","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"R179-36-20241201","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.leu.2403004","article-title":"Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells.","volume":"17","author":"Falanga","year":"2003","journal-title":"Leukemia"},{"key":"R180-36-20241201","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF00169738","article-title":"Coronary endotheliumprotective effects of defibrotide in ischaemia and reperfusion.","volume":"341","author":"Lefer","year":"1990","journal-title":"Naunyn Schmiedebergs Arch Pharmakol"},{"key":"R181-36-20241201","first-page":"737","article-title":"Treatment of severe venoocclusive disease with defibrotide: compassionate use results in response without significant toxicity in a highrisk population.","volume":"92","author":"Richardson","year":"1998","journal-title":"Blood"},{"key":"R182-36-20241201","first-page":"1122","article-title":"Defibrotide for the treatment of hepatic venoocclusive disease: results of the European compassionateuse study.","volume":"111","author":"Chopra","year":"2000","journal-title":"Br J Haematol"},{"key":"R183-36-20241201","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multiinstitutional use of defibrotide in 88 patients after stem cell transplantation with severe venoocclusive disease and multisystem organ failure: response without significant toxicity in a highrisk population and factors predictive of outcome.","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"R184-36-20241201","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of venoocclusive disease with defibrotide after allogeneic stem cell transplantation.","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"R185-36-20241201","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","article-title":"Defibrotide in the treatment of children with venoocclusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention.","volume":"33","author":"Corbacioglu","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R186-36-20241201","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.510240321","article-title":"Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation.","volume":"24","author":"Fried","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R187-36-20241201","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bmt.1702386","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) for severe venoocclusive disease of the liver following bone marrow transplantation.","volume":"25","author":"Azoulay","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R188-36-20241201","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/hep.510310224","article-title":"Support of sinusoidal endothelial cell glutathione prevents hepatic venoocclusive disease in vivo.","volume":"31","author":"Wang","year":"2000","journal-title":"HEPATOLOGY"},{"key":"R189-36-20241201","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/hep.1840380416","article-title":"Decreased Hepatic Nitric Oxide Production Contributes to the Development of Rat Sinusoidal Obstruction Syndrome.","volume":"38","author":"DeLeve","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R190-36-20241201","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0016-5085(03)01056-4","article-title":"Prevention of sinusoidal obstruction syndrome (hepatic venoocclusive disease) in the rat by matrix metalloproteinase inhibitors.","volume":"125","author":"DeLeve","year":"2003","journal-title":"Gastroenterology"},{"key":"R191-36-20241201","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1532\/IJH97.NA0511","article-title":"Sinusoidal obstruction syndrome of the liver after hematopoietic stem cell transplantation: decision making for orthotopic liver transplantation.","volume":"83","author":"Koenecke","year":"2006","journal-title":"Int J Hematol"},{"key":"R192-36-20241201","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00277-005-1076-7","article-title":"Liver transplantation after stem cell transplantation with the same living donor in a monozygotic twin with acute myeloid leukemia.","volume":"84","author":"Mellgren","year":"2005","journal-title":"Ann Hematol"},{"key":"R193-36-20241201","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1034\/j.1600-6143.2002.20815.x","article-title":"A successful liver transplantation for refractory hepatic venoocclusive disease originating from cord blood transplantation.","volume":"2","author":"Kim","year":"2002","journal-title":"Am J Transplant"},{"key":"R194-36-20241201","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0168-8278(02)00434-8","article-title":"BuddChiari syndrome: a review by an expert panel.","volume":"38","author":"Janssen","year":"2003","journal-title":"J Hepatol"},{"key":"R195-36-20241201","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1440-1746.1996.tb00056.x","article-title":"Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal.","volume":"11","author":"Shrestha","year":"1996","journal-title":"J Gastroenterol Hepatol"},{"key":"R196-36-20241201","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1111\/j.1440-1746.2004.03642.x","article-title":"Hepatic venous outflow tract obstruction etipathogenesis: Asia versus the West.","volume":"19","author":"Valla","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"R197-36-20241201","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0025-6196(12)62109-0","article-title":"Classification of hepatic venous outflow obstruction:ambiguous terminology of the BuddChiari syndrome.","volume":"65","author":"Ludwig","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"R198-36-20241201","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/02724936.1992.11747613","article-title":"Pyogenic liver abscess causing acute BuddChiari syndrome.","volume":"12","author":"Mehrotra","year":"1992","journal-title":"Ann Trop Paediatr"},{"key":"R199-36-20241201","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.36.1.142","article-title":"Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment.","volume":"36","author":"Uddin","year":"1995","journal-title":"Gut"},{"key":"R200-36-20241201","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2214\/ajr.179.3.1790759","article-title":"Focal nodular hyperplasia inducing hepatic vein obstruction.","volume":"179","author":"Rangheard","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"R201-36-20241201","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1148\/radiol.2391050387","article-title":"Outcome of percutaneous transhepatic venoplasty for hepatic venous outflow obstruction after living donor liver transplantation.","volume":"239","author":"Kubo","year":"2006","journal-title":"Radiology"},{"key":"R202-36-20241201","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1148\/radiol.2361040327","article-title":"Treatment of hepatic venous outflow obstruction after piggyback liver transplantation.","volume":"236","author":"Wang","year":"2005","journal-title":"Radiology"},{"key":"R203-36-20241201","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0168-8278(98)80298-5","article-title":"Posttraumatic membranous obstruction of the inferior vena cava associated with a hypercoagulable state.","volume":"28","author":"Balian","year":"1998","journal-title":"J Hepatol"},{"key":"R204-36-20241201","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s002619900493","article-title":"BuddChiari syndrome: hepatic venous obstruction by an elevated diaphragm.","volume":"24","author":"Kim","year":"1999","journal-title":"Abdom Imaging"},{"key":"R205-36-20241201","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0009-9260(97)80135-3","article-title":"BuddChiari syndrome resulting from intrahepatic IVC compression secondary to blunt hepatic trauma.","volume":"52","author":"Markert","year":"1997","journal-title":"Clin Radiol"},{"key":"R206-36-20241201","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00005792-199401000-00003","article-title":"Hepatic outflow obstruction (BuddChiari syndrome). Experience with 177 patients and a review of the literature.","volume":"73","author":"Dilawari","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"R207-36-20241201","first-page":"858","article-title":"BuddChiari syndrome: a common complication of Behcets disease.","volume":"92","author":"Bayraktar","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"R208-36-20241201","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0168-8278(97)80044-X","article-title":"Multilineage hemopoietic stem cell defects in Budd Chiari syndrome.","volume":"26","author":"Dayal","year":"1997","journal-title":"J Hepatol"},{"key":"R209-36-20241201","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/gut.48.2.264","article-title":"Factor V Leiden related BuddChiari syndrome.","volume":"48","author":"Deltenre","year":"2001","journal-title":"Gut"},{"key":"R210-36-20241201","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0168-8278(00)80218-4","article-title":"Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the BuddChiari syndrome.","volume":"32","author":"Hirshberg","year":"2000","journal-title":"J Hepatol"},{"key":"R211-36-20241201","first-page":"211","article-title":"Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a casecontrol study.","volume":"24","author":"Kumar","year":"2005","journal-title":"Indian J Gastroenterol"},{"key":"R212-36-20241201","first-page":"214","article-title":"Relations of BuddChiari syndrome to prothrombin gene mutation.","volume":"3","author":"Lin","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R213-36-20241201","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-103-3-329","article-title":"Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with BuddChiari syndrome.","volume":"103","author":"Valla","year":"1985","journal-title":"Ann Intern Med"},{"key":"R214-36-20241201","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1053\/j.gastro.2006.04.008","article-title":"Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the BuddChiari syndrome.","volume":"130","author":"Patel","year":"2006","journal-title":"Gastroenterology"},{"key":"R215-36-20241201","first-page":"1712","article-title":"Myeloproliferative disease in the pathogenesis and survival of BuddChiari syndrome.","volume":"91","author":"Smalberg","year":"2006","journal-title":"Haematologica"},{"key":"R216-36-20241201","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1572-0241.1998.00286.x","article-title":"Significance of elevated IgG anticardiolipin antibody levels in patients with BuddChiari syndrome.","volume":"93","author":"Aggarwal","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R217-36-20241201","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-200111000-00001","article-title":"BuddChiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients.","volume":"80","author":"Espinosa","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"R218-36-20241201","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/j.1572-0241.1999.01447.x","article-title":"Anticardiolipin antibodies in patients with liver disease.","volume":"94","author":"Mangia","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R219-36-20241201","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/ajcn\/77.5.1269","article-title":"Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation.","volume":"77","author":"BosyWestphal","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"R220-36-20241201","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajh.10149","article-title":"Hyperhomocysteinemia and the MTHFR C677T mutation in BuddChiari syndrome.","volume":"71","author":"Li","year":"2002","journal-title":"Am J Hematol"},{"key":"R221-36-20241201","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria.","volume":"333","author":"Hillmen","year":"1995","journal-title":"N Engl J Med"},{"key":"R222-36-20241201","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0016-5085(87)90920-6","article-title":"Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal BuddChiari syndrome.","volume":"93","author":"Valla","year":"1987","journal-title":"Gastroenterology"},{"key":"R223-36-20241201","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00004836-199607000-00019","article-title":"BuddChiari syndrome associated with 5q deletion and hypereosinophilia.","volume":"23","author":"Zylberberg","year":"1996","journal-title":"J Clin Gastroenterol"},{"key":"R224-36-20241201","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0016-5085(88)90444-1","article-title":"Response to steroids in BuddChiari syndrome caused by idiopathic granulomatous venulitis.","volume":"94","author":"Young","year":"1988","journal-title":"Gastroenterology"},{"key":"R225-36-20241201","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/j.1536-4801.2005.tb00934.x","article-title":"Ulcerative colitis complicated by ischemic colitis and Budd Chiari syndrome.","volume":"40","author":"Rahhal","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R226-36-20241201","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0016-5085(86)90855-3","article-title":"Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A casecontrol study.","volume":"90","author":"Valla","year":"1986","journal-title":"Gastroenterology"},{"key":"R227-36-20241201","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0002-9343(80)90180-1","article-title":"BuddChiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract.","volume":"68","author":"Khuroo","year":"1980","journal-title":"Am J Med"},{"key":"R228-36-20241201","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005792-195912000-00002","article-title":"Occlusion of the hepatic veins in man.","volume":"38","author":"Parker","year":"1959","journal-title":"Medicine (Baltimore)"},{"key":"R229-36-20241201","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0016-5085(94)90765-X","article-title":"The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases.","volume":"106","author":"Hadengue","year":"1994","journal-title":"Gastroenterology"},{"key":"R230-36-20241201","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.20064","article-title":"Determinants of survival and the effect of portosystemic shunting in patients with BuddChiari syndrome.","volume":"39","author":"Murad","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R231-36-20241201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-8278(95)80252-5","article-title":"Epidemiological and clinical features of BuddChiari syndrome in Japan.","volume":"22","author":"Okuda","year":"1995","journal-title":"J Hepatol"},{"key":"R232-36-20241201","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/jhep.2003.50076","article-title":"Arterial and portal circulation and parenchymal changes in BuddChiari syndrome: a study in 17 explanted livers.","volume":"37","author":"CazalsHatem","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R233-36-20241201","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00042737-199705000-00014","article-title":"Poor prognosis and limited therapeutic options in patients with BuddChiari syndrome and portal venous system thrombosis.","volume":"9","author":"Mahmoud","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R234-36-20241201","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.510270224","article-title":"Pathology of the liver in BuddChiari syndrome: portal vein thrombosis and the histogenesis of venocentric cirrhosis, venoportal cirrhosis, and large regenerative nodules.","volume":"27","author":"Tanaka","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R235-36-20241201","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1259\/0007-1285-40-478-755","article-title":"Vascular radiology in the BuddChiari syndrome.","volume":"40","author":"Kreel","year":"1967","journal-title":"Br J Radiol"},{"key":"R236-36-20241201","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1051-0443(96)70749-2","article-title":"Percutaneous transhepatic hepatic venography in the delineation and treatment of BuddChiari syndrome.","volume":"7","author":"Wilson","year":"1996","journal-title":"J Vasc Interv Radiol"},{"key":"R237-36-20241201","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/gut.44.4.568","article-title":"Managing BuddChiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting.","volume":"44","author":"Fisher","year":"1999","journal-title":"Gut"},{"key":"R238-36-20241201","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0016-5085(75)80090-4","article-title":"The BuddChiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction.","volume":"68","author":"Tavill","year":"1975","journal-title":"Gastroenterology"},{"key":"R239-36-20241201","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2214\/ajr.159.3.1503015","article-title":"Membranous obstruction of inferior vena cava: comparison of findings at sonography, CT, and venography.","volume":"159","author":"Lim","year":"1992","journal-title":"Am J Roentgenol"},{"key":"R240-36-20241201","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00201775","article-title":"BuddChiari syndrome: imaging with pathologic correlation.","volume":"18","author":"Miller","year":"1993","journal-title":"Abdom Imaging"},{"key":"R241-36-20241201","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1046\/j.1440-1746.1999.01969.x","article-title":"Duplex Doppler sonography in patients with BuddChiari syndrome.","volume":"14","author":"Chawla","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"R242-36-20241201","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2214\/ajr.152.2.377","article-title":"BuddChiari syndrome: the results of duplex and color Doppler imaging.","volume":"152","author":"Grant","year":"1989","journal-title":"AJR Am J Roentgenol"},{"key":"R243-36-20241201","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2214\/ajr.161.2.8333368","article-title":"Color Doppler imaging findings in patients with BuddChiari syndrome: correlation with venographic findings.","volume":"161","author":"Millener","year":"1993","journal-title":"AJR Am J Roentgenol"},{"key":"R244-36-20241201","first-page":"23","article-title":"BuddChiari syndrome: MR evaluation.","volume":"2","author":"Menu","year":"1990","journal-title":"Diagn Interv Radiol"},{"key":"R245-36-20241201","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/gut.28.3.242","article-title":"Comparison of ultrasonography, computed tomography and 99mTc liver scan in diagnosis of BuddChiari syndrome.","volume":"28","author":"Gupta","year":"1987","journal-title":"Gut"},{"key":"R246-36-20241201","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0016-5085(83)90084-7","article-title":"Early diagnosis of BuddChiari syndrome by computed tomography and ultrasonography: report of five cases.","volume":"84","author":"Baert","year":"1983","journal-title":"Gastroenterology"},{"key":"R248-36-20241201","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF01889026","article-title":"Hepatic heterogeneity on CT in BuddChiari syndrome: correlation with regional disturbances in portal flow.","volume":"13","author":"Van Beers","year":"1988","journal-title":"Gastrointest Radiol"},{"key":"R249-36-20241201","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0002-9343(86)90058-6","article-title":"Constrictive pericarditis mimicking BuddChiari syndrome.","volume":"80","author":"Solano","year":"1986","journal-title":"Am J Med"},{"key":"R250-36-20241201","doi-asserted-by":"crossref","first-page":"901","DOI":"10.5858\/2004-128-901-SDACIL","article-title":"Sinusoidal dilatation and congestion in liver biopsy: is it always due to venous outflow impairment?","volume":"128","author":"Kakar","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"R251-36-20241201","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00005792-198503000-00005","article-title":"Membranous obstruction of the inferior vena cava in the United States.","volume":"64","author":"Rector","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"R252-36-20241201","first-page":"1232","article-title":"Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis).","volume":"21","author":"Wanless","year":"1995","journal-title":"HEPATOLOGY"},{"key":"R253-36-20241201","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (venoocclusive disease).","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin Liver Dis"},{"key":"R254-36-20241201","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0168-8278(01)00131-3","article-title":"The prognostic value of histology in the assessment of patients with BuddChiari syndrome.","volume":"35","author":"Tang","year":"2001","journal-title":"J Hepatol"},{"key":"R255-36-20241201","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.510300125","article-title":"Outcome of BuddChiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting.","volume":"30","author":"Zeitoun","year":"1999","journal-title":"HEPATOLOGY"},{"key":"R256-36-20241201","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(84)91181-4","article-title":"Successful pregnancy after BuddChiari syndrome.","volume":"2","author":"Vons","year":"1984","journal-title":"Lancet"},{"key":"R257-36-20241201","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of lowdose aspirin in polycythemia vera.","volume":"350","author":"Landolfi","year":"2004","journal-title":"N Engl J Med"},{"key":"R258-36-20241201","first-page":"511","article-title":"Hepatic transplantation with perioperative and long term anticoagulation as treatment for BuddChiari syndrome.","volume":"166","author":"Campbell","year":"1988","journal-title":"Surg Gynecol Obstet"},{"key":"R259-36-20241201","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000658-199001000-00007","article-title":"Liver transplantation for the BuddChiari syndrome.","volume":"211","author":"Halff","year":"1990","journal-title":"Ann Surg"},{"key":"R260-36-20241201","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1399-0012.2005.00374.x","article-title":"High incidence of recurrence and hematologic events following liver transplantation for BuddChiari syndrome.","volume":"19","author":"Cruz","year":"2005","journal-title":"Clin Transplant"},{"key":"R262-36-20241201","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/hep.1840210518","article-title":"Which is the best surgery for BuddChiari syndrome: venous decompression or liver transplantation? A singlecenter experience with 50 patients.","volume":"21","author":"Ringe","year":"1995","journal-title":"HEPATOLOGY"},{"key":"R263-36-20241201","first-page":"453","article-title":"Portosystemic shunt versus orthotopic liver transplantation for the BuddChiari syndrome.","volume":"174","author":"Shaked","year":"1992","journal-title":"Surg Gynecol Obstet"},{"key":"R264-36-20241201","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00007890-200203270-00026","article-title":"Liver transplantation for BuddChiari syndrome.","volume":"73","author":"Srinivasan","year":"2002","journal-title":"Transplantation"},{"key":"R265-36-20241201","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2005.12.002","article-title":"Liver transplantation for BuddChiari syndrome: A European study on 248 patients from 51 centres.","volume":"44","author":"Mentha","year":"2006","journal-title":"J Hepatol"},{"key":"R266-36-20241201","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.3748\/wjg.v9.i11.2587","article-title":"Longterm effect of stent placement in 115 patients with BuddChiari syndrome.","volume":"9","author":"Zhang","year":"2003","journal-title":"World J Gastroenterol"},{"key":"R267-36-20241201","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/hep.21354","article-title":"Aiming at minimal invasiveness as a therapeutic strategy for BuddChiari syndrome.","volume":"44","author":"Plessier","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R268-36-20241201","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2003.09.028","article-title":"Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature.","volume":"40","author":"Sharma","year":"2004","journal-title":"J Hepatol"},{"key":"R269-36-20241201","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.20990","article-title":"Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe BuddChiari syndrome.","volume":"43","author":"HernandezGuerra","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R270-36-20241201","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/hep.510250405","article-title":"Hepatic venous outflow block caused by shortlength hepatic vein stenoses.","volume":"25","author":"Valla","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R271-36-20241201","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2002-23203","article-title":"Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy).","volume":"22","author":"Okuda","year":"2002","journal-title":"Semin Liver Dis"},{"key":"R272-36-20241201","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0009-9260(96)80005-5","article-title":"Radiological intervention in BuddChiari syndrome: techniques and outcome in 18 patients.","volume":"51","author":"Griffith","year":"1996","journal-title":"Clin Radiol"},{"key":"R273-36-20241201","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2214\/ajr.154.5.2138842","article-title":"Angioplasty for longterm treatment of patients with BuddChiari syndrome.","volume":"154","author":"Martin","year":"1990","journal-title":"AJR Am J Roentgenol"},{"key":"R274-36-20241201","first-page":"461","article-title":"Interventional radiology, angioplasty and TIPS in BuddChiari syndrome.","volume":"26","author":"Nunez","year":"2003","journal-title":"in Spanish Gastroenterol Hepatol"},{"key":"R275-36-20241201","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00330-002-1475-2","article-title":"BuddChiari syndrome due to prothrombotic disorder: midterm patency and efficacy of endovascular stents.","volume":"13","author":"Pelage","year":"2003","journal-title":"Eur Radiol"},{"key":"R276-36-20241201","first-page":"318","article-title":"Interventional endovascular treatment for BuddChiari syndrome with longterm followup.","volume":"135","author":"Qiao","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"R277-36-20241201","first-page":"498","article-title":"Hepatic vein stenting for BuddChiari syndrome.","volume":"92","author":"Witte","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"R278-36-20241201","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jvs.2005.09.003","article-title":"Primary BuddChiari syndrome: outcome of endovascular management for suprahepatic venous obstruction.","volume":"43","author":"Lee","year":"2006","journal-title":"J Vasc Surg"},{"key":"R279-36-20241201","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1148\/radiology.176.3.2143840","article-title":"Hepatic inferior vena cava obstruction: treatment of two types with Gianturco expandable metallic stents.","volume":"176","author":"Furui","year":"1990","journal-title":"Radiology"},{"key":"R280-36-20241201","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1051-0443(96)70800-X","article-title":"Management of idiopathic BuddChiari syndrome with primary stent placement: early results.","volume":"7","author":"Baijal","year":"1996","journal-title":"J Vasc Interv Radiol"},{"key":"R281-36-20241201","first-page":"760","article-title":"Diagnosis and treatment of membraneous obstruction of the inferior vena cava.","volume":"28","author":"Guan","year":"1990","journal-title":"in Chinese Zhonghua Wai Ke Za Zhi"},{"key":"R282-36-20241201","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0140-6736(93)91712-U","article-title":"Management of hepatic venous outflow obstruction.","volume":"342","author":"Kohli","year":"1993","journal-title":"Lancet"},{"key":"R283-36-20241201","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02575472","article-title":"Percutaneous transluminal angioplasty in segmental obstruction of the hepatic inferior vena cava: longterm results.","volume":"13","author":"Sato","year":"1990","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R284-36-20241201","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1148\/radiology.149.1.6225147","article-title":"Segmental obstruction of the hepatic inferior vena cava treated by transluminal angioplasty.","volume":"149","author":"Yamada","year":"1983","journal-title":"Radiology"},{"key":"R285-36-20241201","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0002-8703(92)90605-U","article-title":"Nonoperative treatment of membranous obstruction of the inferior vena cava by percutaneous balloon transluminal angioplasty.","volume":"124","author":"Yang","year":"1992","journal-title":"Am Heart J"},{"key":"R286-36-20241201","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s002709900117","article-title":"Interventional therapeutic techniques in BuddChiari syndrome.","volume":"20","author":"Bilbao","year":"1997","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R287-36-20241201","first-page":"151","article-title":"Management of the BuddChiari syndrome by balloon cavoplasty.","volume":"20","author":"De","year":"2001","journal-title":"Indian J Gastroenterol"},{"key":"R288-36-20241201","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1440-1746.2005.03878.x","article-title":"BuddChiari syndrome: longterm effect on outcome with transjugular intrahepatic portosystemic shunt.","volume":"20","author":"Khuroo","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"R289-36-20241201","first-page":"362","article-title":"Percutaneous balloon angioplasty of membranous obstruction of the inferior vena cava.","volume":"55","author":"Mishra","year":"2003","journal-title":"Indian Heart J"},{"key":"R290-36-20241201","first-page":"378","article-title":"Balloon dilatation of inferior vena cava stenosis in BuddChiari syndrome.","volume":"44","author":"Tyagi","year":"1996","journal-title":"J Assoc Physicians India"},{"key":"R291-36-20241201","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-5273(02)00037-2","article-title":"Percutaneous balloon angioplasty of inferior vena cava in BuddChiari syndromeR1.","volume":"83","author":"Wu","year":"2002","journal-title":"Int J Cardiol"},{"key":"R292-36-20241201","first-page":"111","article-title":"Interventional or semiinterventional treatment for BuddChiari syndrome.","volume":"18","author":"Xiaoming","year":"2003","journal-title":"Chin Med Sci J"},{"key":"R293-36-20241201","first-page":"609","article-title":"Clinical application of interventional techniques in the treatment of BuddChiari syndrome.","volume":"116","author":"Xu","year":"2003","journal-title":"Chin Med J (Engl)"},{"key":"R294-36-20241201","first-page":"155","article-title":"Is surgical portosystemic shunt the treatment of choice in BuddChiari syndrome?","volume":"65","author":"Langlet","year":"2002","journal-title":"Acta Gastroenterol Belg"},{"key":"R295-36-20241201","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2006.08.016","article-title":"Longterm portosystemic shunt patency as a determinant of outcome in BuddChiari syndrome.","volume":"46","author":"Bachet","year":"2007","journal-title":"J Hepatol"},{"key":"R296-36-20241201","first-page":"276","article-title":"Portosystemic shunt in BuddChiari syndrome: longterm survival and factors affecting shunt patency in 25 patients in Western countries.","volume":"115","author":"Panis","year":"1994","journal-title":"Surgery"},{"key":"R297-36-20241201","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0168-8278(03)00323-4","article-title":"Clinicopathological forms and prognostic index in BuddChiari syndrome.","volume":"39","author":"Langlet","year":"2003","journal-title":"J Hepatol"},{"key":"R298-36-20241201","first-page":"522","article-title":"Management of severe BuddChiari syndrome: report of 147 cases.","volume":"3","author":"Feng","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R299-36-20241201","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1051-0443(91)72230-6","article-title":"Percutaneous intervention in portosystemic shunts in BuddChiari syndrome.","volume":"2","author":"Savader","year":"1991","journal-title":"J Vasc Interv Radiol"},{"key":"R300-36-20241201","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00000658-199111000-00008","article-title":"Portasystemic shunting versus liver transplantation for the BuddChiari syndrome.","volume":"214","author":"Bismuth","year":"1991","journal-title":"Ann Surg"},{"key":"R301-36-20241201","first-page":"603","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) for BuddChiari syndrome or portal vein thrombosis: review of indications and problems.","volume":"94","author":"Ganger","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R302-36-20241201","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1051-0443(99)70118-1","article-title":"Role of TIPS as a bridge to hepatic transplantation in BuddChiari syndrome.","volume":"10","author":"Ryu","year":"1999","journal-title":"J Vasc Interv Radiol"},{"key":"R303-36-20241201","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000658-200104000-00007","article-title":"BuddChiari syndrome: current management options.","volume":"233","author":"Slakey","year":"2001","journal-title":"Ann Surg"},{"key":"R304-36-20241201","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1051-0443(07)61938-1","article-title":"Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in patients with BuddChiari syndrome.","volume":"13","author":"Cejna","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"R305-36-20241201","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/jhep.2002.30274","article-title":"TIPS is a useful longterm derivative therapy for patients with BuddChiari syndrome uncontrolled by medical therapy.","volume":"35","author":"Perello","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R306-36-20241201","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1053\/jhep.2002.33199","article-title":"Longterm effect of treatment of acute BuddChiari syndrome with a transjugular intrahepatic portosytemic shunt.","volume":"35","author":"Blokzijl","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R307-36-20241201","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0168-8278(03)00118-1","article-title":"TIPS for acute and chronic BuddChiari syndrome: a singlecentre experience.","volume":"38","author":"Mancuso","year":"2003","journal-title":"J Hepatol"},{"key":"R308-36-20241201","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1440-1746.2004.03427.x","article-title":"Acute BuddChiari syndrome with liver failure: the experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt.","volume":"19","author":"Kavanagh","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"R309-36-20241201","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1365-2036.2004.02190.x","article-title":"Treatment of BuddChiari syndrome in a liver transplant unit, the role of transjugular intrahepatic portosystemic shunt and liver transplantation.","volume":"20","author":"Attwell","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R310-36-20241201","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.surg.2003.09.005","article-title":"The BuddChiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt.","volume":"135","author":"Rossle","year":"2004","journal-title":"Surgery"},{"issue":"Suppl 3","key":"R311-36-20241201","first-page":"38","article-title":"BuddChiari syndrome and TIPS-twelve years experience.","volume":"144","author":"Safka","year":"2005","journal-title":"in Czech Cas Lek Cesk"},{"key":"R313-36-20241201","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/gut.2005.071423","article-title":"Favourable medium term outcome following hepatic vein recanalisation andor transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome.","volume":"55","author":"Eapen","year":"2006","journal-title":"Gut"},{"key":"R314-36-20241201","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/hep.20436","article-title":"PTFEcovered stents improve TIPS patency in BuddChiari syndrome.","volume":"40","author":"HernandezGuerra","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R315-36-20241201","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1067\/msy.2000.108209","article-title":"Surgical shunts and TIPS for variceal decompression in the 1990s.","volume":"128","author":"Henderson","year":"2000","journal-title":"Surgery"},{"key":"R316-36-20241201","first-page":"362","article-title":"Liver transplantation for BuddChiari syndrome, 1976-1990.","volume":"45","author":"Jamieson","year":"1991","journal-title":"Ann Chir"},{"key":"R317-36-20241201","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/lt.21220","article-title":"Twenty years of liver transplantation for BuddChiari syndrome: a national registry analysis.","volume":"13","author":"Segev","year":"2007","journal-title":"Liver Transpl"},{"key":"R318-36-20241201","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/00007890-200210270-00006","article-title":"Hematologic aspects of liver transplantation for BuddChiari syndrome with special reference to myeloproliferative disorders.","volume":"74","author":"Melear","year":"2002","journal-title":"Transplantation"},{"key":"R319-36-20241201","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gut.2005.078048","article-title":"Prognosis in Budd Chiari syndrome after reestablishing hepatic venous drainage.","volume":"55","author":"Valla","year":"2006","journal-title":"Gut"},{"key":"R320-36-20241201","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/lt.500030410","article-title":"Reassessing the role of medical therapy in the management of hepatic vein thrombosis.","volume":"3","author":"Min","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"R321-36-20241201","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"key":"R322-36-20241201","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1572-0241.2003.07183.x","article-title":"BuddChiari syndrome and hepatocellular carcinoma: a case report and review of the literature.","volume":"98","author":"Havlioglu","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R323-36-20241201","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/gut.2007.139477","article-title":"Hepatocellular carcinoma in BuddChiari syndrome: characteristics and risk factors.","volume":"57","author":"Moucari","year":"2008","journal-title":"Gut"},{"key":"R324-36-20241201","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00042737-200403000-00012","article-title":"Characteristic clinical features of hepatocellular carcinoma associated with BuddChiari syndrome: evidence of different carcinogenic process from hepatitis B virusassociated hepatocellular carcinoma.","volume":"16","author":"Shin","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R325-36-20241201","first-page":"461A","article-title":"Hepatocellular carcinoma in BuddChiari syndrome: characteristics and risk factors. Abstract.","volume":"44","author":"Moucari","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R326-36-20241201","first-page":"243","article-title":"BuddChiari syndrome in children. Apropos of 7 cases.","volume":"48","author":"Boudhina","year":"1991","journal-title":"in French Arch Fr Pediatr"},{"key":"R327-36-20241201","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0022-3476(88)80524-9","article-title":"BuddChiari syndrome in children: report of 22 cases.","volume":"113","author":"GentilKocher","year":"1988","journal-title":"J Pediatr"},{"key":"R328-36-20241201","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0022-5223(05)80158-8","article-title":"Surgical repair in children with the BuddChiari syndrome.","volume":"110","author":"Odell","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R329-36-20241201","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1572-0241.2006.00353.x","article-title":"Pathogenesis and treatment of BuddChiari syndrome combined with portal vein thrombosis.","volume":"101","author":"Murad","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R330-36-20241201","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1148\/radiographics.22.1.g02ja08141","article-title":"Congenital and acquired anomalies of the portal venous system.","volume":"22","author":"Gallego","year":"2002","journal-title":"Radiographics"},{"key":"R331-36-20241201","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1478-3231.2006.01340.x","article-title":"Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations.","volume":"26","author":"Buscarini","year":"2006","journal-title":"Liver Int"},{"key":"R332-36-20241201","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (RenduOslerWeber syndrome).","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"R333-36-20241201","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00261-003-0131-x","article-title":"Congenital absence of the portal vein associated with focal nodular hyperplasia in the liver in an adult woman: imaging and review of the literature.","volume":"29","author":"De Gaetano","year":"2004","journal-title":"Abdom Imaging"},{"key":"R334-36-20241201","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2214\/ajr.183.5.1831333","article-title":"Hepatic nodular lesions associated with abnormal development of the portal vein.","volume":"183","author":"Kim","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"R335-36-20241201","first-page":"427","article-title":"Partial nodular transformation of liver in an adult with persistent ductus venosus. Review with hypothesis on pathogenesis.","volume":"109","author":"Wanless","year":"1985","journal-title":"Arch Pathol Lab Med"},{"key":"R336-36-20241201","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s003300051012","article-title":"Congenital absence of portal vein with nodular regenerative hyperplasia of the liver.","volume":"10","author":"Grazioli","year":"2000","journal-title":"Eur Radiol"},{"key":"R337-36-20241201","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ultrasmedbio.2004.08.004","article-title":"High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia.","volume":"30","author":"Buscarini","year":"2004","journal-title":"Ultrasound Med Biol"},{"key":"R338-36-20241201","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJM200009283431305","article-title":"Liver disease in patients with hereditary hemorrhagic telangiectasia.","volume":"343","author":"GarciaTsao","year":"2000","journal-title":"N Engl J Med"},{"key":"R339-36-20241201","first-page":"331","article-title":"Nodular transformation of the liver in hereditary hemorrhagic telangiectasia.","volume":"110","author":"Wanless","year":"1986","journal-title":"Arch Pathol Lab Med"},{"key":"R340-36-20241201","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng0696-189","article-title":"Mutations in the activin receptorlike kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.","volume":"13","author":"Johnson","year":"1996","journal-title":"Nat Genet"},{"key":"R341-36-20241201","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1294-345","article-title":"Endoglin, a TGFbeta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1.","volume":"8","author":"McAllister","year":"1994","journal-title":"Nat Genet"},{"key":"R342-36-20241201","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/rg.281075037","article-title":"Abdominal findings in hereditary hemorrhagic telangiectasia: pictorial essay on 2D and 3D findings with isotropic multiphase CT.","volume":"28","author":"Siddiki","year":"2008","journal-title":"Radiographics"},{"key":"R343-36-20241201","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1148\/radiol.2301021745","article-title":"Hereditary hemorrhagic telangiectasia: multidetector row helical CT assessment of hepatic involvement.","volume":"230","author":"Ianora","year":"2004","journal-title":"Radiology"},{"key":"R344-36-20241201","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2007.12.022","article-title":"Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: EchocolorDoppler vs multislice computed tomography study.","volume":"48","author":"Buonamico","year":"2008","journal-title":"J Hepatol"},{"key":"R345-36-20241201","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2006.12.008","article-title":"Liver involvement in hereditary hemorrhagic telangiectasia (HHT).","volume":"46","author":"GarciaTsao","year":"2007","journal-title":"J Hepatol"},{"key":"R346-36-20241201","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1399-0004.2008.01029.x","article-title":"Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia.","volume":"74","author":"Brakensiek","year":"2008","journal-title":"Clin Genet"},{"key":"R347-36-20241201","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/GIM.0b013e31802d8373","article-title":"Genotypephenotype correlations in hereditary hemorrhagic telangiectasia: data from the FrenchItalian HHT network.","volume":"9","author":"Lesca","year":"2007","journal-title":"Genet Med"},{"key":"R348-36-20241201","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1538-7836.2007.02531.x","article-title":"Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers.","volume":"5","author":"Sabba","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R349-36-20241201","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ajmg.a.31101","article-title":"Genotypephenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations.","volume":"140","author":"BayrakToydemir","year":"2006","journal-title":"Am J Med Genet"},{"key":"R350-36-20241201","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jmg.2005.035451","article-title":"Genotype phenotype relationship in hereditary hemorrhagic telangiectasia.","volume":"43","author":"Letteboer","year":"2006","journal-title":"J Med Genet"},{"key":"R351-36-20241201","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2559.2003.01579.x","article-title":"The pathology of acute hepatic disintegration in hereditary haemorrhagic telangiectasia.","volume":"42","author":"Blewitt","year":"2003","journal-title":"Histopathology"},{"key":"R352-36-20241201","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1053\/jhep.2003.50197","article-title":"Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT).","volume":"37","author":"Caselitz","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R353-36-20241201","doi-asserted-by":"crossref","first-page":"W399","DOI":"10.2214\/AJR.05.1068","article-title":"Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients.","volume":"187","author":"Wu","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"R354-36-20241201","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0028-1085093","article-title":"Hepatic vascular malformations in hereditary hemorrhagic telangiectasia.","volume":"28","author":"Khalid","year":"2008","journal-title":"Semin Liver Dis"},{"key":"R355-36-20241201","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.20066","article-title":"Management of adult patients with ascites due to cirrhosis.","volume":"39","author":"Runyon","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R356-36-20241201","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/01.sla.0000247258.35406.a4","article-title":"Liver transplantation for hereditary hemorrhagic telangiectasia: report of the European Liver Transplant Registry.","volume":"244","author":"Lerut","year":"2006","journal-title":"Ann Surg"},{"issue":"Suppl 3","key":"R357-36-20241201","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1002\/lt.20978","article-title":"MELD exception for hereditary hemorrhagic telangiectasia.","volume":"12","author":"GarciaTsao","year":"2006","journal-title":"Liver Transpl"},{"key":"R358-36-20241201","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0016-5085(99)70243-X","article-title":"Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement.","volume":"116","author":"Boillot","year":"1999","journal-title":"Gastroenterology"},{"key":"R359-36-20241201","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1478-3231.2005.01116.x","article-title":"Extensive ischemic liver necrosis complicating hereditary hemorrhagic telangiectasia: a rare indication for liver transplantation.","volume":"25","author":"Dominguez","year":"2005","journal-title":"Liver Int"},{"key":"R360-36-20241201","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/jlts.2001.21313","article-title":"Hepatic involvement in hereditary hemorrhagic telangiectasia: an unusual indication for liver transplantation.","volume":"7","author":"Hillert","year":"2001","journal-title":"Liver Transpl"},{"key":"R361-36-20241201","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00277-006-0147-8","article-title":"Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab.","volume":"85","author":"Flieger","year":"2006","journal-title":"Ann Hematol"},{"key":"R362-36-20241201","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/lt.21417","article-title":"Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.","volume":"14","author":"Mitchell","year":"2008","journal-title":"Liver Transpl"},{"key":"R363-36-20241201","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/rg.243035046","article-title":"Congenital hepatic shunts.","volume":"24","author":"Gallego","year":"2004","journal-title":"Radiographics"},{"key":"R364-36-20241201","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0022-3468(94)90812-5","article-title":"Congenital absence of the portal vein: two cases and a proposed classification system for portasystemic vascular anomalies.","volume":"29","author":"Morgan","year":"1994","journal-title":"J Pediatr Surg"},{"key":"R365-36-20241201","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00247-003-1002-x","article-title":"Congenital extrahepatic portosystemic shunts.","volume":"33","author":"Murray","year":"2003","journal-title":"Pediatr Radiol"},{"key":"R366-36-20241201","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1016\/j.jpedsurg.2003.09.035","article-title":"Patent ductus venosus in children: a case report and review of the literature.","volume":"39","author":"Yoshimoto","year":"2004","journal-title":"J Pediatr Surg"},{"key":"R367-36-20241201","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2004.01.013","article-title":"Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts.","volume":"40","author":"Ortiz","year":"2004","journal-title":"J Hepatol"},{"key":"R368-36-20241201","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/lt.20170","article-title":"Orthotopic liver transplantation for portosystemic encephalopathy in an adult with congenital absence of the portal vein.","volume":"10","author":"Wojcicki","year":"2004","journal-title":"Liver Transpl"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22772","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200905000-00036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:47:54Z","timestamp":1733060874000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200905000-00036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":361,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22772","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}